45 related articles for article (PubMed ID: 29786141)
1. An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.
von Neubeck B; Gondi G; Riganti C; Pan C; Parra Damas A; Scherb H; Ertürk A; Zeidler R
Int J Cancer; 2018 Oct; 143(8):2065-2075. PubMed ID: 29786141
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.
Battke C; Kremmer E; Mysliwietz J; Gondi G; Dumitru C; Brandau S; Lang S; Vullo D; Supuran C; Zeidler R
Cancer Immunol Immunother; 2011 May; 60(5):649-58. PubMed ID: 21298264
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase XII functions in health and disease.
Waheed A; Sly WS
Gene; 2017 Aug; 623():33-40. PubMed ID: 28433659
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII.
Giuntini G; Monaci S; Cau Y; Mori M; Naldini A; Carraro F
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080820
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex.
Alterio V; Kellner M; Esposito D; Liesche-Starnecker F; Bua S; Supuran CT; Monti SM; Zeidler R; De Simone G
J Mol Biol; 2019 Dec; 431(24):4910-4921. PubMed ID: 31682835
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body.
Pan C; Schoppe O; Parra-Damas A; Cai R; Todorov MI; Gondi G; von Neubeck B; Böğürcü-Seidel N; Seidel S; Sleiman K; Veltkamp C; Förstera B; Mai H; Rong Z; Trompak O; Ghasemigharagoz A; Reimer MA; Cuesta AM; Coronel J; Jeremias I; Saur D; Acker-Palmer A; Acker T; Garvalov BK; Menze B; Zeidler R; Ertürk A
Cell; 2019 Dec; 179(7):1661-1676.e19. PubMed ID: 31835038
[TBL] [Abstract][Full Text] [Related]
7. Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull-meninges connections.
Cai R; Pan C; Ghasemigharagoz A; Todorov MI; Förstera B; Zhao S; Bhatia HS; Parra-Damas A; Mrowka L; Theodorou D; Rempfler M; Xavier ALR; Kress BT; Benakis C; Steinke H; Liebscher S; Bechmann I; Liesz A; Menze B; Kerschensteiner M; Nedergaard M; Ertürk A
Nat Neurosci; 2019 Feb; 22(2):317-327. PubMed ID: 30598527
[TBL] [Abstract][Full Text] [Related]
8. Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models-Implications for Therapy.
Rotermund A; Brandt S; Staege MS; Luetzkendorf J; Mueller LP; Mueller T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982873
[TBL] [Abstract][Full Text] [Related]
9. Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor.
Han R; Yang H; Ling C; Lu L
Cancer Cell Int; 2022 Nov; 22(1):368. PubMed ID: 36424626
[TBL] [Abstract][Full Text] [Related]
10. New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells.
Braconi L; Teodori E; Riganti C; Coronnello M; Nocentini A; Bartolucci G; Pallecchi M; Contino M; Manetti D; Romanelli MN; Supuran CT; Dei S
J Med Chem; 2022 Nov; 65(21):14655-14672. PubMed ID: 36269278
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
Hiepp L; Mayr D; Gärtner K; Schmoeckel E; Klauschen F; Burges A; Mahner S; Zeidler R; Czogalla B
PLoS One; 2022; 17(7):e0271630. PubMed ID: 35901081
[TBL] [Abstract][Full Text] [Related]
12. The complex relationship between multiple drug resistance and the tumor pH gradient: a review.
Koltai T
Cancer Drug Resist; 2022; 5(2):277-303. PubMed ID: 35800371
[TBL] [Abstract][Full Text] [Related]
13. High-Resolution 3D Heart Models of Cardiomyocyte Subpopulations in Cleared Murine Heart.
Ren H; Pu Z; Sun T; Chen T; Liu L; Liu Z; O'Shea C; Pavlovic D; Tan X; Lei M
Front Physiol; 2022; 13():779514. PubMed ID: 35665220
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.
Tonissen KF; Poulsen SA
Cancer Drug Resist; 2021; 4(2):343-355. PubMed ID: 35582034
[TBL] [Abstract][Full Text] [Related]
15. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.
Kciuk M; Gielecińska A; Mujwar S; Mojzych M; Marciniak B; Drozda R; Kontek R
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1278-1298. PubMed ID: 35506234
[TBL] [Abstract][Full Text] [Related]
16. Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies.
Brenna C; Simioni C; Varano G; Conti I; Costanzi E; Melloni M; Neri LM
Histochem Cell Biol; 2022 May; 157(5):497-511. PubMed ID: 35235045
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Molecular Docking Study of Novel 3-Phenyl-β-Alanine-Based Oxadiazole Analogues as Potent Carbonic Anhydrase II Inhibitors.
Rafiq K; Ur Rehman N; Halim SA; Khan M; Khan A; Al-Harrasi A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164091
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.
Bagheri A; Culp PA; DuBridge RB; Chen TT
Biochem Biophys Rep; 2022 Mar; 29():101205. PubMed ID: 35071801
[TBL] [Abstract][Full Text] [Related]
19. Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms.
Giovannuzzi S; D'Ambrosio M; Luceri C; Osman SM; Pallecchi M; Bartolucci G; Nocentini A; Supuran CT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008884
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells.
Huang T; Tang L; Wang H; Lin L; Fu J
Bioengineered; 2021 Dec; 12(2):9806-9818. PubMed ID: 34696661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
